obiltoxaximab
Sign in to saveObiltoxaximab, sold under the brand name Anthim among others, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).
Wikidata facts
- Subclass of
- chemical compound
- Has use
- medication
Show 2 more facts
- subject has role
- monoclonal antibody
- legal status (medicine)
- boxed warning
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
5 sectionsContents
- Medical uses
- Adverse effects
- Legal status
- References
- External links
Obiltoxaximab, sold under the brand name Anthim among others, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).
The medication was developed by Elusys Therapeutics, Inc.
Excerpted from Wikipedia’s “obiltoxaximab” article, available under the CC BY-SA 4.0 licence.